Overall rank by patents
#25,618
of 50,000 tracked assignees
USPTO PatentsView assignee record - 10 granted patents across 7 technology areas, recorded in grant years 2018–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR).
The verdict
According to USPTO PatentsView, 410 ranks #25,618 of 50,000 tracked US assignees by granted-patent volume, with 10 patents across 7 technology areas.
USPTO PatentsView assignee plate
Corpus R25618 · US Corporation #25,618 · 10 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL
Nearest grant-volume peer: 1ST Biotherapeutics, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
410 Medical · this assignee
40 score
3D Lighting Innovati… · lowest
7 score
What this shows 410's Innovation Score is 40.3/100 (top 36% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
410 Medical, Inc. is a focused PatentsView assignee: 7 CPC subclasses with 100% of grants classified under A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR). Peak complete grant year is 2019 (2 grants) versus a trough of 1 in 2018. By volume, 410 sits between 1ST Biotherapeutics, Inc. and 9155-0020 Quebec Inc..
410 Medical, Inc. shows 5 grants in 2022–2024 against only 4 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
1ST BIOTHERAPEUTICS, INC.
10 patents
1st Defence Industries Ltd.
10 patents
2nd Skull, Inc.
10 patents
3D PLUS
10 patents
4DS MEMORY, LIMITED
10 patents
7Tunnels Inc.
10 patents
80 Percent Arms Inc.
10 patents
9155-0020 Quebec Inc.
10 patents
410 Medical, Inc.
10 patents
What this shows 410 holds 10 patents at rank #25,618, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #25,618 in granted patent volume.
Other assignees with the most granted patents in 410's primary technology class.
410's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
40 Top 36% higher than 64% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2018 | 1 | 10.0% |
| 2019 | 2 | 20.0% |
| 2020 | 2 | 20.0% |
| 2022 | 1 | 10.0% |
| 2023 | 2 | 20.0% |
| 2024 | 2 | 20.0% |
Top 7 of 7 technology areas
Overall rank by patents
#25,618
of 50,000 tracked assignees
40.3 out of 100
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.